<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-29T02:37:31Z</responseDate><request verb="GetRecord" identifier="oai:repisalud.isciii.es:20.500.12105/18881" metadataPrefix="mets">https://repisalud.isciii.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:repisalud.isciii.es:20.500.12105/18881</identifier><datestamp>2024-11-28T15:24:04Z</datestamp><setSpec>com_20.500.12105_15322</setSpec><setSpec>com_20.500.12105_2051</setSpec><setSpec>col_20.500.12105_16927</setSpec></header><metadata><mets xmlns="http://www.loc.gov/METS/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="&#xa;&#x9;&#x9;&#x9;&#x9;DSpace_ITEM_20.500.12105-18881" TYPE="DSpace ITEM" PROFILE="DSpace METS SIP Profile 1.0" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd" OBJID="&#xa;&#x9;&#x9;&#x9;&#x9;hdl:20.500.12105/18881">
   <metsHdr CREATEDATE="2026-04-29T04:37:31Z">
      <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
         <name>Repisalud</name>
      </agent>
   </metsHdr>
   <dmdSec ID="DMD_20.500.12105_18881">
      <mdWrap MDTYPE="MODS">
         <xmlData xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
            <mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Mascaraque, Ainhoa</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Kowalczyk, Wioleta</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Fernández, Tahia</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Palomares, Francisca</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Mayorga, Cristobalina</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Andreu, David</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Rojo, Javier</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">authoraffiliation</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>[Mascaraque,A; Rojo,J] Glycosystems Laboratory, Instituto de Investigaciones Químicas (IIQ), CSIC-Universidad de Sevilla, Seville, Spain. [Kowalczyk,W, Andreu,D] Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain. [Fernández,T; Palomares,F; Mayorga,C] Laboratory of Research, UGC de Alergología, IBIMA, Hospital Regional Universitario de Málaga, UMA, Málaga, Spain.</mods:namePart>
               </mods:name>
               <mods:extension>
                  <mods:dateAccessioned encoding="iso8601">2024-03-05T07:39:00Z</mods:dateAccessioned>
               </mods:extension>
               <mods:extension>
                  <mods:dateAvailable encoding="iso8601">2024-03-05T07:39:00Z</mods:dateAvailable>
               </mods:extension>
               <mods:originInfo>
                  <mods:dateIssued encoding="iso8601">2015-10</mods:dateIssued>
               </mods:originInfo>
               <mods:identifier type="issn">2040-2511</mods:identifier>
               <mods:identifier type="other">http://hdl.handle.net/10668/2274</mods:identifier>
               <mods:identifier type="uri">http://hdl.handle.net/20.500.12105/18881</mods:identifier>
               <mods:identifier type="doi">10.1039/C5MD00133A</mods:identifier>
               <mods:identifier type="e-issn">2040-2503</mods:identifier>
               <mods:identifier type="journal">MedChemComm</mods:identifier>
               <mods:abstract>Mannosylation facilitates uptake and internalization of immunogenic peptides by antigen-processing cells expressing mannose receptors at their surface, such as DC-SIGN, a lectin that plays a key role in the immune response against different pathogens. This internalization, processing and subsequent MHC presentation may result in a strong T cell stimulation. Here, we hypothesized that combining mannose glycodendrons with multivalent presentation of peptide epitopes in a likewise dendron format would yield hybrid constructs, named glycodendropeptides (GDPs), with the capacity to enhance peptide immunogenicity, hence providing a novel and versatile platform for applications in immunotherapy. Thus, GDPs of different valencies displaying the NP366-374 epitope, a conserved sequence from the influenza A virus nucleoprotein (NP), have been built by two click chemistry-based methodologies and assessed as potential flu vaccine candidates. Preliminary evaluation of the ability of these constructs to stimulate dendritic cell maturation and lymphocyte proliferation was promising, showing the highest-functionalized NP366-374 GDPs as inducing the strongest immunostimulatory effect.</mods:abstract>
               <mods:language>
                  <mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
               </mods:language>
               <mods:accessCondition type="useAndReproduction"/>
               <mods:subject>
                  <mods:topic>Moléculas de adhesión celular</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Química clic</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Secuencia conservada</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Dendrómeros</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Células dendróticas</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Epítopos</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Inmunoterapia</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Lectinas tipo C</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Manosa</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Lectinas de unión a manosa</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Péptidos</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Proteínas de unión al ARN</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Receptores de superficie celular</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Linfocitos T</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Vacunas</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Proteínas del centro vírico</mods:topic>
               </mods:subject>
               <mods:titleInfo>
                  <mods:title>Glycodendropeptides stimulate dendritic cell maturation and T cell proliferation: a potential influenza A virus immunotherapy</mods:title>
               </mods:titleInfo>
               <mods:genre>research article</mods:genre>
            </mods:mods>
         </xmlData>
      </mdWrap>
   </dmdSec>
   <structMap LABEL="DSpace Object" TYPE="LOGICAL">
      <div TYPE="DSpace Object Contents" ADMID="DMD_20.500.12105_18881"/>
   </structMap>
</mets></metadata></record></GetRecord></OAI-PMH>